Nicotinell

Nicotine, the active ingredient in Nicotinell, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adult smokers who wish to quit by reducing cravings and withdrawal symptoms associated with nicotine dependence. Nicotinell is marketed throughout the European Union as an over‑the‑counter product and is supplied in a single‑dose patch format.

GNH USA supplies Nicotinell as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell, a nicotine replacement therapy, is used to support smoking cessation.

- Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms during a quit attempt. - Relapse prevention: provides a controlled nicotine supply to lower the risk of returning to tobacco use. - Adjunct to behavioral programs: can be combined with counseling or support groups to improve quit rates.

Common side effects are generally mild and related to the patch application site or systemic nicotine exposure.

Common Side Effects: - Skin irritation: redness, itching, or rash at the site of application. - Localized burning or tingling sensation. - Headache. - Nausea or upset stomach. - Dizziness. - Sleep disturbances, such as vivid dreams.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Extensive skin blistering or dermatitis. - Rapid heart rate or palpitations. - Chest pain. - Severe hypotension. - Seizures (very rare).

Before using Nicotinell, consider the following safety measures.

- Cardiovascular assessment: patients with recent heart attack or unstable angina should consult a physician. - Non‑smoker use: the patch is not indicated for individuals who do not use tobacco. - Skin integrity: avoid applying to damaged, irritated, or infected skin. - Site rotation: change the application site each day to minimize skin irritation. - Store at room temperature: keep patches in the original packaging, protect from moisture and direct heat.

Nicotinell may interact with other substances that affect nicotine levels or cardiovascular function.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): combined use can increase the risk of hypertensive crisis. - Concurrent nicotine products (e.g., gum, lozenges, e‑cigarettes): may lead to nicotine overdose. - Bupropion: co‑administration can raise seizure risk.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., certain antifungals): may alter nicotine metabolism. - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Alcohol: can increase nicotine clearance, potentially reducing efficacy.